Keynote Panel Discussion – From Risk Identification to Risk Minimisation: Reimagining Pharmacovigilance Risk Management Across the Product Lifecycle

Name: Keynote Panel Discussion – From Risk Identification to Risk Minimisation: Reimagining Pharmacovigilance Risk Management Across the Product Lifecycle
Start: 2027-03-11T11:10
Location: Sheraton Skyline Hotel London Heathrow

Pharmacovigilance UK & EU 2027 · 11 March 2027 · 11:10

Keynote Panel Discussion – From Risk Identification to Risk Minimisation: Reimagining Pharmacovigilance Risk Management Across the Product Lifecycle was a session at Pharmacovigilance UK & EU 2027 on 11 March 2027 in London, with 5 speakers on record.

Speakers

Pav Rishiraj — Moderator Director, Head of Pharmacovigilance, Ipsen
Sumit Munjal — Panelist Global Head of Medical Safety, Otsuka Pharmaceutical Companies Europe
Sabine Poltermann — Panelist IPS Lead – Risk Management, Bristol Myers Squibb
Krupa Patel — Panelist Safety Evaluation and Risk Management Director UK, GSK
Jean Kilgour-Christie — Panelist Sandoz